Skip to main content
. 2022 Jul 29;12(8):1058. doi: 10.3390/biom12081058

Figure 1.

Figure 1

IGHG2 and IGHG3 expression levels were examined in 571 CRC patient samples following RNA-seq (TCGA-COAD dataset). There was no evidence of a unique sub-population of patients with elevated IGHG3 expression within the CRC population. However, we did find a significant association between the levels of IGHG2 (x-axis) and IGHG3 (y-axis) expression suggesting the transcription of these constant regions have similar expression profiles in CRC patients (p = 8.25 × 10−145).